Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   ADCOCK INGRAM
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
ADCOCK INGRAM
Jun-14
ALKEM LABORATORIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,625320-   
Low Rs2,835231-   
Sales per share (Unadj.) Rs970.195.1-  
Earnings per share (Unadj.) Rs84.2-24.0-  
Cash flow per share (Unadj.) Rs110.2-19.9-  
Dividends per share (Unadj.) Rs50.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs756.474.6-  
Shares outstanding (eoy) m119.57168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.32.9 115.1%   
Avg P/E ratio x38.4-11.5 -334.1%  
P/CF ratio (eoy) x29.3-13.9 -211.6%  
Price / Book Value ratio x4.33.7 115.8%  
Dividend payout %59.40-   
Avg Mkt Cap Rs m386,20746,446 831.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m21,3142,915 731.2%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m115,99316,052 722.6%  
Other income Rs m2,161112 1,922.2%   
Total revenues Rs m118,15316,165 730.9%   
Gross profit Rs m15,065-2,782 -541.5%  
Depreciation Rs m3,104693 448.1%   
Interest Rs m1,074435 246.9%   
Profit before tax Rs m13,048-3,797 -343.6%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,980237 1,255.8%   
Profit after tax Rs m10,068-4,045 -248.9%  
Gross profit margin %13.0-17.3 -74.9%  
Effective tax rate %22.8-6.2 -365.5%   
Net profit margin %8.7-25.2 -34.4%  
BALANCE SHEET DATA
Current assets Rs m86,06411,757 732.0%   
Current liabilities Rs m37,0716,615 560.4%   
Net working cap to sales %42.232.0 131.9%  
Current ratio x2.31.8 130.6%  
Inventory Days Days33111 29.4%  
Debtors Days Days67124 54.1%  
Net fixed assets Rs m37,2456,853 543.5%   
Share capital Rs m23975 320.8%   
"Free" reserves Rs m90,2080-   
Net worth Rs m90,44712,599 717.9%   
Long term debt Rs m04,428 0.0%   
Total assets Rs m124,54123,801 523.3%  
Interest coverage x13.2-7.7 -170.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 138.1%   
Return on assets %8.9-15.2 -59.0%  
Return on equity %11.1-32.1 -34.7%  
Return on capital %15.6-19.8 -78.8%  
Exports to sales %14.60-   
Imports to sales %00-   
Net fx Rs m12,7270-   
CASH FLOW
From Operations Rs m16,8251,370 1,227.9%  
From Investments Rs m1,128-421 -268.2%  
From Financial Activity Rs m-17,6084,018 -438.2%  
Net Cashflow Rs m4164,968 8.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare ALKEM LABORATORIES With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: ALBERT DAVID  SUVEN LIFE SCIENCES  STRIDES PHARMA SCIENCE  VIVIMED LABS  BH.IMMUN&BIO  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.